Interesting and Dynamic Change While we may never know exactly why Lena Kozovski was demoted there is no mistaking that Andrew Ryu is working to put his stamp over everything. From alluding to the need to wean away from covid testing (although a Fall/Winter surge in covid would keep testing at the forefront) to the associated moves with both Naturevan and Conceirge Medical he is methodically and decisively directing the growth ....something that seemed to be waning at the end of Lena's tenure.
It is unlikely any significant benefits of this won't be realized officially until the Q4 2022 financials released in 2023. Hopefully, and in the meantime, positive NRs connected to same will generate some momentum for the sp. One sign of the contribution that today's NR will have on growth will be in job postings over the next few months.
GLTE ....holding patiently!!!